Australian Neuroscience Society - 30th Annual Meeting and Australian Physiological Society - 50th Anniversary Meeting.
The joint 30th Annual Meeting of the Australian Neuroscience Society and the 50th Anniversary Meeting of the Australian Physiological Society, held in Sydney, included topics covering new developments in the fields of neuroscience and physiology. This conference report highlights selected presentations on potential treatments for neuropathic pain, mood disorders and Alzheimer's disease. Investigational drugs discussed include 4-ACPBPA (Circadian Technologies Ltd/University of Sydney) and F-15599 (Pierre Fabre SA).
Hannan
Anthony J
AJ
University of Melbourne, Howard Florey Institute, Florey Neuroscience Institutes, Royal Parade, Parkville, VIC, Australia. anthony.hannan@florey.edu.au
D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D001315:Australia; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002492:Central Nervous System Depressants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D020916:Conotoxins / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D019964:Mood Disorders / Q000188:drug therapy / Q000378:metabolism; D009462:Neurology; D010146:Pain / Q000188:drug therapy; D010827:Physiology; D012955:Societies, Medical; D013107:Sphingolipids / Q000096:biosynthesis
D002492:Central Nervous System Depressants; D020916:Conotoxins; D004791:Enzyme Inhibitors; D013107:Sphingolipids